Scoping review: hotspots for COVID-19 urological research: what is being published and from where?

Qu, Liang G.; Perera, Marlon; Lawrentschuk, Nathan; Umbas, Rainy; Klotz, Laurence

doi:10.1007/s00345-020-03434-2

“…Three reviews used Tableau (one of them also used review management software as discussed above) [ 22 – 24 ]. Two reviews generated maps using ArcGIS [ 25 ] or ArcMap [ 26 ]. One review used Leximancer for a lexical analysis [ 27 ].…”

Section: Resultsmentioning

confidence: 99%

Data visualisation in scoping reviews and evidence maps on health topics: a cross-sectional analysis

South,

Rodgers

2023

Syst Rev

4

0

View full text Add to dashboard Cite

Background Scoping reviews and evidence maps are forms of evidence synthesis that aim to map the available literature on a topic and are well-suited to visual presentation of results. A range of data visualisation methods and interactive data visualisation tools exist that may make scoping reviews more useful to knowledge users. The aim of this study was to explore the use of data visualisation in a sample of recent scoping reviews and evidence maps on health topics, with a particular focus on interactive data visualisation. Methods Ovid MEDLINE ALL was searched for recent scoping reviews and evidence maps (June 2020-May 2021), and a sample of 300 papers that met basic selection criteria was taken. Data were extracted on the aim of each review and the use of data visualisation, including types of data visualisation used, variables presented and the use of interactivity. Descriptive data analysis was undertaken of the 238 reviews that aimed to map evidence. Results Of the 238 scoping reviews or evidence maps in our analysis, around one-third (37.8%) included some form of data visualisation. Thirty-five different types of data visualisation were used across this sample, although most data visualisations identified were simple bar charts (standard, stacked or multi-set), pie charts or cross-tabulations (60.8%). Most data visualisations presented a single variable (64.4%) or two variables (26.1%). Almost a third of the reviews that used data visualisation did not use any colour (28.9%). Only two reviews presented interactive data visualisation, and few reported the software used to create visualisations. Conclusions Data visualisation is currently underused by scoping review authors. In particular, there is potential for much greater use of more innovative forms of data visualisation and interactive data visualisation. Where more innovative data visualisation is used, scoping reviews have made use of a wide range of different methods. Increased use of these more engaging visualisations may make scoping reviews more useful for a range of stakeholders.

show abstract

“…There are several studies published in literature exploring the effect of COVID-19 on the provision of urological procedures as highlighted by the scoping review published by Qu et al. [ 4 ]. Although not captured in this study, Mandanelo et al.…”

Section: Discussionmentioning

confidence: 99%

The impact of the coronavirus disease 2019 pandemic on elective urological procedures in Australia

John

¹

,

Mian

²

,

Sreedharan

³

et al. 2022

Asian Journal of Urology

View full text Add to dashboard Cite

Objective To investigate the changes in elective private urological procedures in Australia during the coronavirus disease 2019 pandemic. Methods Data were extracted from publicly available datasets from Medicare Benefits Schedule (MBS) using item numbers assigned to each commonly performed urological intervention. These procedures were divided into three groups: Oncological therapeutic, diagnostic, and non-oncological therapeutic procedures. A smoothing model, based on the historic procedure numbers from 2017 to 2019, was used to forecast monthly number of procedures performed in each category between January and June 2020. These forecasted models were compared with reported figures. Results A total of 108 169 procedures performed between January and June 2020 based on the MBS item numbers listed. There was a significant reduction (percentage change) in total procedures performed in April (−22.6%, 95% confidence interval [CI]: −15.4% to −28.7%) and May 2020 (−33.2%, 95% CI: −28.3% to −37.5%). There was a significant reduction in oncological therapeutic, non-oncological therapeutic, and diagnostic procedures performed in April and May 2020 (P < 0.05). These numbers did not include procedures performed in public sector. Conclusions There was a significant reduction in total urological procedures (including diagnostic, oncological, and non-oncological) performed in months of April and May 2020 during time of federal restrictions. Both public and private healthcare sectors need to be supported in the upcoming months to prevent further delays in treatment and poorer clinical outcomes.

show abstract

“…

After an initial focus on the immediate respiratory implications of COVID19, its downstream effect on the practice of urology has rapidly become apparent. Urologists have been quick to recognise the ensuing challenges, that have ranged from prioritising patients who needed inpatient treatment when hospitals were under unprecedented pressure [1,2], to adjustment of research so that it might potentially benefit those with COVID19 [3,4], to ensuring that novel strategies for patient care and even medical education using digital technologies were implemented [5,6].Urologists as a group have been ideally placed to respond to these challenges. Experience with conditions that affect patients on a broad spectrum of severity [7], plus the development of extensive datasets that could then be assessed for the impact of COVID19 [8] have enabled a measured and consequential assessment of how urologic care can be optimised during this uncertain time.Urologists have proven capable of adjusting numerous aspects of patient care due to the impact of COVID19.

…”

mentioning

confidence: 99%

“…After an initial focus on the immediate respiratory implications of COVID19, its downstream effect on the practice of urology has rapidly become apparent. Urologists have been quick to recognise the ensuing challenges, that have ranged from prioritising patients who needed inpatient treatment when hospitals were under unprecedented pressure [1,2], to adjustment of research so that it might potentially benefit those with COVID19 [3,4], to ensuring that novel strategies for patient care and even medical education using digital technologies were implemented [5,6].…”

mentioning

confidence: 99%

COVID19: the response of the urologist

Bolton

¹

2021

World J Urol

0

View full text Add to dashboard Cite

After an initial focus on the immediate respiratory implications of COVID19, its downstream effect on the practice of urology has rapidly become apparent. Urologists have been quick to recognise the ensuing challenges, that have ranged from prioritising patients who needed inpatient treatment when hospitals were under unprecedented pressure [1,2], to adjustment of research so that it might potentially benefit those with COVID19 [3,4], to ensuring that novel strategies for patient care and even medical education using digital technologies were implemented [5,6].Urologists as a group have been ideally placed to respond to these challenges. Experience with conditions that affect patients on a broad spectrum of severity [7], plus the development of extensive datasets that could then be assessed for the impact of COVID19 [8] have enabled a measured and consequential assessment of how urologic care can be optimised during this uncertain time.Urologists have proven capable of adjusting numerous aspects of patient care due to the impact of COVID19. While the ultimate cumulative effect of this virus upon those requiring [9] and offering [10] urologic care is still to be determined, the considered and significant research on this topic undertaken to date appears to have ensured that an overwhelming secondary impact upon both of these groups has been avoided. Thanks for this are due in no small part to those urologists who have pivoted their research to the topic of COVID19 in the absence of pre-existing funding for this purpose.Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

show abstract

Scoping review: hotspots for COVID-19 urological research: what is being published and from where?

Cited by 3 publications

References 62 publications

Data visualisation in scoping reviews and evidence maps on health topics: a cross-sectional analysis

Data visualisation in scoping reviews and evidence maps on health topics: a cross-sectional analysis

The impact of the coronavirus disease 2019 pandemic on elective urological procedures in Australia

COVID19: the response of the urologist

Contact Info

Product

Resources

About